Finance

Lists
Why is 086900 up 2.29%?
Dive Deeper
086900:KOSDAQ
Medy-Tox Inc.
â‚©71,500.00
+2.29%
(+1,600.00) 1D
Nov 13, 3:30:22 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 086900...
Open
â‚©70,000
High
â‚©73,700
Low
â‚©69,900
Mkt. cap
521.84B
Avg. vol.
19.97K
Volume
34.02K
Dividend
1.68%
Quarterly dividend
â‚©300
Ex-dividend date
Oct 28, 2026
P/E ratio
34.42
52-wk high
â‚©141,100
52-wk low
â‚©61,200
EPS
â‚©2,077
Shares outstanding
7.30M
No. of employees
703
Open
â‚©70,000
High
â‚©73,700
Low
â‚©69,900
Mkt. cap
521.84B
Avg. vol.
19.97K
Volume
34.02K
Dividend
1.68%
Quarterly dividend
â‚©300
Ex-dividend date
Oct 28, 2026
P/E ratio
34.42
52-wk high
â‚©141,100
52-wk low
â‚©61,200
EPS
â‚©2,077
Shares outstanding
7.30M
No. of employees
703
News stories
From web sources and news partners
About Medy-Tox Inc.
CEOJung Hyunho
Employees703
FoundedMay 2, 2000
HeadquartersGangnam District, Seoul, South Korea
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
61.02B
60.67B
60.69B
68.70B
Cost of goods sold
24.60B
24.93B
18.92B
27.63B
Cost of revenue
24.60B
24.93B
18.92B
27.63B
Research and development expenses
-
29.19B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.52B
2.31B
34.39B
36.31B
Operating expense
27.52B
39.75B
34.39B
36.31B
Total operating expenses
52.12B
64.68B
53.32B
63.94B
Operating income
8.90B
-4.01B
7.37B
4.76B
Other non operating income
-519.03M
-1.19B
1.51B
807.29M
EBT including unusual items
7.78B
-13.98B
9.70B
4.26B
EBT excluding unusual items
7.78B
-10.68B
9.70B
4.26B
Income tax expense
581.80M
-10.93B
1.82B
1.13B
Effective tax rate
7.48%
78.14%
18.78%
26.57%
Other operating expenses
-
1.41B
-
-
Net income
7.43B
-3.02B
7.80B
3.11B
Net profit margin
12.18%
-4.97%
12.85%
4.52%
Earnings per share
-
-493.00
1.19K
479.00
Interest and investment income
-
1.40B
-
-
Interest expense
-
-649.39M
-
-
Net interest expenses
-
745.76M
-
-
Depreciation and amortization charges
-
1.57B
-
-
EBITDA
13.89B
1.00B
12.39B
9.78B
Gain or loss from assets sale
-
4.31B
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps